• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Fenofibrate

Fenofibrate

Product ID F1853
Cas No. 49562-28-9
Purity ≥98%
Product Unit SizeCostQuantityStock
5 g $63.90 In stock
25 g $187.40 In stock
100 g $385.90 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Fenofibrate is a fibric acid derivative fibrate compound that exhibits anti-hyperlipidemic, anti-fibrotic, and anticancer chemotherapeutic activities. Fenofibrate activates PPARα, stimulating lipoprotein lipase and increasing lipolysis; this results in decreases in overall triglyceride, VLDL, and LDL levels as well as increases in HDL levels. Fenofibrate decreases oxidative stress-induced expression of α-SMA, TGF-β1, IL-6, collagen-1, and TNF-α, preventing CCL4-induced hepatic fibrosis. Fenofibrate also upregulates expression of Bad, downregulates expression of Bcl-xl, survivin, cyclin D1, and CDK4, activates caspase-3 and NF-κB, and induces G0/G1 phase cell cycle arrest in breast cancer cells, suppressing cell and tumor growth in both in vitro and in vivo models.

Product Info

Cas No.

49562-28-9

Purity

≥98%

Formula

C20H21ClO4

Formula Wt.

360.83

Chemical Name

2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid 1-methylethyl ester

IUPAC Name

propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate

Synonym

Ankebin, Elasterin, Fempbrate, Lipantil, Lipoclar, Lipofene, Nolipax, Secalip, Tricor

Melting Point

80-81°C

Solubility

Soluble in acetone, ether, benzene and chloroform. Slightly soluble in methanol and ethanol. Practically insoluble in water.

Appearance

White to off white powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

F1853 MSDS PDF

Info Sheet

F1853 Info Sheet PDF

References

Gao Y, Shen W, Zhang Q, et al. Up-regulation of Hepatic VLDLR via PPARα Is Required for the Triglyceride-Lowering Effect of Fenofibrate. J Lipid Res. 2014 Jun 4. [Epub ahead of print]. PMID: 24899625.

Li T, Zhang Q, Zhang J, et al. Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway. BMC Cancer. 2014 Feb 16;14:96. PMID: 24529079.

Xie C, Li L, Xu YP, et al. Anti-fibrosis effects of fenofibrate in mice with hepatic fibrosis. Zhonghua Gan Zang Bing Za Zhi. 2013 Dec;21(12):914-9. PMID: 24636293.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • H0001

    H7

    PKC and PKG inhibitor.

    ≥98%
  • V3251

    Vinorelbine Base

    Semi-synthetic vinca alkaloid found in Catharan...

    ≥90%
  • C1648

    α-Cembrenediol

    Diterpene found in Anisomeles.

    ≥99%
  • M5793

    Moxifloxacin Free Base

    Fluoroquinolone; topoisomerase IV, topoisomeras...

    ≥98%
  • D4802

    17-Dimethylaminoethylamino Demethoxygeldanamycin

    Geldanamycin derivative; HSP90 inhibitor.

    ≥98%
  • R327201

    Rifapentine

    Antibiotic

    ≥97%
  • V014463

    Valsartan Methyl Ester

    Valsartan impurity

    ≥98%
  • S6129

    D-Sphingosine

    Endogenous component of sphingolipids; PKC inhi...

    ≥98%
  • C9673

    Cysteamine Hydrochloride

    Aminothiol, CoA component; ulcer inducer.

    ≥99%
  • U6956

    Uroguanylin, human

    Endogenous peptide, involved in water/Na+ homeo...

    ≥95%
  • K0021

    K252a

    Staurosporine analog; PKC inhibitor, TrkA/B ant...

    ≥98%
  • F1654

    Fenoldopam Mesylate

    Benzazepine derivative; D1 partial agonist, pot...

    ≥98%
  • E4416

    Eledoisin

    Peptide, substance P analog; NK agonist.

    ≥95%
  • A985136

    AZD5991

    Mcl-1 inhibitor

    ≥99%
  • S8046

    R-Sulforaphane, High Purity

    Naturally occuring isothiocyanate found in broc...

    ≥98%
  • P6818

    Prednisolone

    Cortisol derivative; glucocorticoid agonist.

    ≥98%
  • S8110

    Sucralfate

    Antacid; pepsin inhibitor. Assay (Polysaccharid...

    Assay (Polysaccharide sulfate) 30-38%
  • M1685

    Mevastatin

    Statin; HMG-CoA reductase inhibitor.

    ≥98%
  • K7600

    KT5720

    PKA and PDK1 inhibitor, HCN channel blocker, po...

    ≥98%
  • U698578

    Urolithin C

    Ellagic acid derivative produced by gut microfl...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only